The anti CD47 drugs market is estimated to be valued at USD 0.14 Bn in 2024 and is expected to reach USD 1.7 Bn by 2031, growing at a compound annual growth rate (CAGR) of 42.9% from 2024 to 2031. https://www.writerscafe.org/kajalpatil/blogs/Immunotherapies-is-Anticipated-to-Witness-High-Growth-Owing-to-Increasing-Application-of-Anti-CD47-Drugs-Market-in-Cancer-Treatment-/245064/